Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective multicenter observational study of apatinib in advanced cancer
ChiCTR-OPN-15007034Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Sep 2015
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Rivoceranib in cancer and gastric cancer (GC), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Progression-free survival. Started Sep 2015; status: recruiting.
02
Drugs
Rivoceranib
03
Conditions
cancergastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-OPN-15007034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15007034.